A phase II challenge study of a univeral influenza vaccine candidate, FLU-v, in healthy volunteers who were exposed to an attenuated strain of influenza.
Phase of Trial: Phase II
Latest Information Update: 08 Nov 2011
At a glance
- Drugs FLU-v (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 08 Nov 2011 New trial record